Search results
Results from the WOW.Com Content Network
Vestibular migraine (VM) is vertigo with migraine, either as a symptom of migraine or as a related neurological disorder.. A 2010 report from the University of British Columbia published in the journal Headache said that " 'Migraine associated vertigo' is emerging as a popular diagnosis for patients with recurrent vertigo" but, "in contrast to basilar artery migraine, is neither clinically nor ...
Vestibular disease is an uncommon condition in older dogs. Most cases are idiopathic, but it can also be caused by otitis interna, or inner ear infection, tumors, and encephalitis. Signs include nystagmus, head tilt, circling, vomiting, and falling to one side. Idiopathic vestibular disease will usually resolve in a few days to a few weeks. [180]
Vestibular migraine is the association of vertigo and migraines and is one of the most common causes of recurrent, spontaneous episodes of vertigo. [3] [10] The cause of vestibular migraines is currently unclear; [3] [40] however, one hypothesized cause is that the stimulation of the trigeminal nerve leads to nystagmus in individuals with ...
There are three critical aspects to the theory: first is the close linkage between activity in the vestibular system, i.e., semicircular canals and otolith organs, and a change in tonus among various of each eye's six extra-ocular muscles. Thus, with the exception of voluntary eye movements, the vestibular and oculomotor systems are thoroughly ...
Sulfasalazine, sold under the brand name Azulfidine among others, is a medication used to treat rheumatoid arthritis, ulcerative colitis, and Crohn's disease. [5] It is considered by some to be a first-line treatment in rheumatoid arthritis. [ 6 ]
Rescue treatment involves acute symptomatic control with medication. [4] Recommendations for rescue therapy of migraine include: (1) migraine-specific agents such as triptans, CGRP antagonists, or ditans for patients with severe headaches or for headaches that respond poorly to analgesics, (2) non-oral (typically nasal or injection) route of administration for patients with vomiting, (3) avoid ...
The patient lies on their back on a bed with their head overhanging the bed. In the first step the head is turned as backward (hanging) as possible. In the following step, the patient remains lying but lifts their head with the chin close to the chest. In the last step, the patient sits upright with the head in the normal position.
Maropitant (INN; [3] brand name: Cerenia, used as maropitant citrate , is a neurokinin-1 (NK 1) receptor antagonist developed by Zoetis specifically for the treatment of motion sickness and vomiting in dogs. It was approved by the FDA in 2007, for use in dogs [4] [5] and in 2012, for cats. [6]